Gregory Lane, MD
Orthopaedic Surgery · Edison, NJNPI 1750488466
Payments from drug & device makers
Across 36 payments — averaging $37.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$243
- Stryker$199
- Zynex Medical, Inc.$149
- Arthrex$140
- Maxx Orthopedics, Inc.$115
- Bioventus LLC$113
- plus $383 from 13 others
What the payments were for
- Food & beverage$1,343100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $243 |
| Stryker | 4 | $199 |
| Zynex Medical, Inc. | 1 | $149 |
| Arthrex | 1 | $140 |
| Maxx Orthopedics, Inc. | 1 | $115 |
| Bioventus LLC | 5 | $113 |
| Dynasplint Systems Inc. | 1 | $60 |
| Vertex | 3 | $50 |
| Johnson & Johnson | 3 | $47 |
| Nalu Medical, Inc. | 1 | $35 |
| Abbott | 1 | $32 |
| Electronic Waveform Lab, Inc. | 2 | $31 |
| Amgen | 2 | $28 |
| Zyla Life Sciences, Inc. | 2 | $25 |
| Avanos Medical | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Orthogenrx Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nexwave$149
- INSPACE$117
- Freedom Total Knee System$115
- Freedom PCK$115
- Regeneten$102
- Coblation Wands$102
How this compares
$1,343 in reported general payments places this provider in the 40th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 61 | $2,858 |
| Ibuprofen | 65 | $595 |
| Naproxen | 62 | $468 |
| Celecoxib | 34 | $427 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $356 |
| Tramadol Hcl | 64 | $271 |
| Zolpidem Tartrate | 32 | $126 |
| Clindamycin Hcl | 37 | $93 |
| Cyclobenzaprine Hcl | 23 | $83 |
| Methylprednisolone | 12 | $62 |
| Meloxicam | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Edison
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Luke AustinSewell$4.3M
- Randal BetzLawrenceville$3M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Gregg KleinParamus$1.6M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Michael AstParamus$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.